Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox vs Steroid for Lateral Epicondylalgia
NCT02767635Phase 3Unknown
- Sponsor
- National Cheng Kung University Hospital
- Start
- Jan 2012
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in lateral epicondylitis, sponsored by National Cheng Kung University Hospital. Primary endpoint: Visual Analogue Scale at 16 weeks. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
lateral epicondylitis
Beyond the preview
Go deeper on NCT02767635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767635.